are we back to this now?
we know what it is....the market knows what it is
we need positive ongoing reporting of this:
example:
an interim DSMB ( or bi- quarterly ) would drive value if the outcomes are being successful
it would draw market attention and volume which drives retail liquidity ....
not more HRECs on other indications .....they can occur in parallel but not as additional clinical investigations
I could be completely wrong but I'm not feeling comfortable with the progress or strategic direction of the last 6 months - these guys should be driving value in the current tightening macro - NTI 164 for autism is a total gamechanger globally ....drive it toward volume and liquidity or the company assets will realise no advantage
as I said - i could be completely wrong
- Forums
- ASX - By Stock
- NTI
- Ann: NTI Receives HREC Approval for Rett Syndrome Clinical Trial
Ann: NTI Receives HREC Approval for Rett Syndrome Clinical Trial, page-6
-
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NTI (ASX) to my watchlist
(20min delay)
|
|||||
Last
4.8¢ |
Change
-0.002(4.00%) |
Mkt cap ! $49.66M |
Open | High | Low | Value | Volume |
5.0¢ | 5.0¢ | 4.8¢ | $30.91K | 632.3K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 445029 | 4.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
4.9¢ | 50000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 445029 | 0.048 |
6 | 1235489 | 0.047 |
4 | 1728152 | 0.046 |
3 | 147240 | 0.045 |
1 | 22000 | 0.044 |
Price($) | Vol. | No. |
---|---|---|
0.049 | 50000 | 1 |
0.050 | 100000 | 1 |
0.051 | 409998 | 2 |
0.053 | 80000 | 1 |
0.054 | 63420 | 1 |
Last trade - 15.56pm 16/10/2024 (20 minute delay) ? |
Featured News
NTI (ASX) Chart |
The Watchlist
JBY
JAMES BAY MINERALS LIMITED
Andrew Dornan, Executive Director
Andrew Dornan
Executive Director
SPONSORED BY The Market Online